-
1
-
-
3242775459
-
eEurope 2002: Quality criteria for health related websites
-
Commission of the European Communities, Brussels, Belgium. eEurope 2002: quality criteria for health related websites. J Med Internet Res 2002;4:e15.
-
(2002)
J Med Internet Res
, vol.4
-
-
-
2
-
-
0034701282
-
Guidelines for medical and health information sites on the internet - Principles governing AMA web sites
-
Winker MA, Flanagin A, Chi-Lum B, White J, Andrews K, Kennett RL, et al. Guidelines for medical and health information sites on the internet - principles governing AMA web sites. JAMA 2000;283:1600-6.
-
(2000)
JAMA
, vol.283
, pp. 1600-1606
-
-
Winker, M.A.1
Flanagin, A.2
Chi-Lum, B.3
White, J.4
Andrews, K.5
Kennett, R.L.6
-
3
-
-
4344638042
-
International research networks in pediatric rheumatology: The PRINTO perspective
-
Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004;16:566-70.
-
(2004)
Curr Opin Rheumatol
, vol.16
, pp. 566-570
-
-
Ruperto, N.1
Martini, A.2
-
4
-
-
12244292516
-
-
Group Techniques for program planning Glenview, Ill.: Scott, Foresman and Company
-
Delbecq AL, Van de Ven AH, Gustafson DH. Group Techniques for program planning. A guide to nominal group and Delphi processes, 1st ed. Glenview, Ill.: Scott, Foresman and Company, 1975.
-
(1975)
A Guide to Nominal Group and Delphi Processes, 1st Ed.
-
-
Delbecq, A.L.1
Van De Ven, A.H.2
Gustafson, D.H.3
-
5
-
-
0033600435
-
Clinical trials, consensus conferences, and clinical practice
-
Sniderman AD. Clinical trials, consensus conferences, and clinical practice. Lancet 1999;354:327-30.
-
(1999)
Lancet
, vol.354
, pp. 327-330
-
-
Sniderman, A.D.1
-
6
-
-
0030960980
-
Preliminary definition of improvement in juvenile arthritis
-
Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
-
(1997)
Arthritis Rheum
, vol.40
, pp. 1202-1209
-
-
Giannini, E.H.1
Ruperto, N.2
Ravelli, A.3
Lovell, D.J.4
Felson, D.T.5
Martini, A.6
-
7
-
-
3142718093
-
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
-
Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9.
-
(2003)
Rheumatology (Oxford)
, vol.42
, pp. 1452-1459
-
-
Ruperto, N.1
Ravelli, A.2
Murray, K.J.3
Lovell, D.J.4
Andersson-Gare, B.5
Feldman, B.M.6
-
8
-
-
0034959826
-
Expanding the guideline for electronic communication with patients. Application to a specific tool
-
Prady SL, Norris D, Lester JE, Hoch DB. Expanding the guideline for electronic communication with patients. Application to a specific tool. J Am Med Inform Assoc 2001;8:344-8.
-
(2001)
J Am Med Inform Assoc
, vol.8
, pp. 344-348
-
-
Prady, S.L.1
Norris, D.2
Lester, J.E.3
Hoch, D.B.4
-
9
-
-
0032888041
-
A look at the future of pediatric therapeutics: An investigator's perspective of the new pediatric rule
-
Connor JD. A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule. Pediatrics 1999;104:610-13.
-
(1999)
Pediatrics
, vol.104
, pp. 610-613
-
-
Connor, J.D.1
-
10
-
-
4344618879
-
Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biologic products in pediatrics patients (21 CFR Parts 201, 312, 314, and 601)
-
FDA. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biologic products in pediatrics patients (21 CFR Parts 201, 312, 314, and 601). Federal Register 1998:63.
-
(1998)
Federal Register
, pp. 63
-
-
-
11
-
-
85007680228
-
Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children
-
Ruperto N, Martini A, for the Paediatric Rheumatology International Trials Organization (PRINTO). Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children. BMJ 2000;320:1210-11.
-
(2000)
BMJ
, vol.320
, pp. 1210-1211
-
-
Ruperto, N.1
Martini, A.2
|